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Severalstudiespointoutthatoxidativestressmaybeamajorculpritindiabeticnephropathy.AqueousextractofHibiscussabdariﬀa
L. (HSE) has been demonstrated as having beneﬁcial eﬀects on anti-oxidation and lipid-lowering in experimental studies. This
study aimed at investigating the eﬀects of Hibiscus sabdariﬀa L. on diabetic nephropathy in streptozotocin induced type 1 diabetic
rats. Our results show that HSE is capable of reducing lipid peroxidation, increasing catalase and glutathione activities signiﬁcantly
in diabetic kidney, and decreasing the plasma levels of triglyceride, low-density lipoprotein (LDL) and increasing high-density
lipoprotein (HDL) value. In histological examination, HSE improves hyperglycemia-caused osmotic diuresis in renal proximal
convoluted tubules (deﬁned as hydropic change) in diabetic rats. The study also reveals that up-regulation of Akt/Bad/14-3-3γ
and NF-κB-mediated transcription might be involved. In conclusion, our results show that HSE possesses the potential eﬀects to
ameliorate diabetic nephropathy via improving oxidative status and regulating Akt/Bad/14-3-3γ signaling.
1.Introduction
Diabetic mellitus (DM) is a consequence of chronic meta-
bolic aberrations including hyperlipidemia. High glucose
facilitating the glycolysis and adenosine triphosphate gen-
eration would cause huge reactive oxygen species (ROS)
production [1]. Under physiological circumstances, ROS
involve some signaling molecules and follow defense mech-
anisms such as phagocytosis, neutrophil function and shear-
stress induced vasorelaxation. However, excessive oxidative
stress could damage proteins, lipids, and DNA and eliminate
anti-oxidative enzymes or molecules [2]. Ujihara et al.
observed that oxidized low-density lipoprotein (LDL) level
was signiﬁcantly higher in diabetic patients with macroal-
buminuria. They suggested that oxidized-LDL might play an
important role in diabetic nephropathy [3]. Experimentally,
the oxidative level of LDL can be determined by detecting
lipid peroxidation. Antioxidant defense mechanisms include
free radical scavengers and enzyme systems, such as super-
oxide dismutase (SOD), glutathione peroxidase (GSH) and
catalase (CAT). Previous studies showed that these anti-
oxidative molecules were reduced in diabetes.
In addition to the devastating damage eﬀect on macro-
molecules, oxidative stress can be involved in cellular signal2 Evidence-Based Complementary and Alternative Medicine
transduction including Akt signaling pathway [4, 5]. Akt
is a principal mediator of biological functions of insulin
in glucose metabolism. Phosphorylated Akt can regulate
apoptosis via activating Bad to associate with 14-3-3γ
protein and also to activate nuclear factor-kappa B (NF-
κB) to regulate transcription [6–9]. Recent studies showed
the importance of phosphoinositide 3-kinases (PI3-K) and
Akt signaling pathway in diabetic nephropathy including
regulation of renal mesangial hypertrophy and renal tubular
cells proteolysis [10, 11]. It has been well known that hyper-
glycemia and insulin could modulate Akt activity in diabetic
renaltissue[12–14].However,theresultsarenotcompatible.
Furthermore, the correlation between oxidative stress and
Akt signaling in diabetic renal tissues has not been well
clariﬁed.
A wide variety of natural products have been found to
possesscapacitytocontrolmetabolicproblemsandoxidative
stress in diabetes. Hibiscus sabdariﬀa Linnaeus (Malvaceae,
local name Roselle) is usually used as a beverage in Southeast
Asia. The constituents in the ﬂowers of Hibiscus species are
polyphenolic acids, ﬂavonoids, and anthocyanins. Previous
studies found that HSE possessed anti-oxidative character-
istics [15] and had anti-atherosclerotic eﬀects [16]. Recent
pharmacological studies also showed that HSE signiﬁcantly
reduced blood pressure in humans [17] and in experimental
animals [18].
The aim of this study is to assess the eﬀect of HSE on
anti-oxidation and on regulation of Akt signaling pathway
in diabetic nephropathy. The morphologic change of renal
tissues is observed. The GSH level, CAT activity and lipid
peroxidation are measured in renal tissues. The Akt/Bad/14-
3-3γ signaling cascade and NF-κB are also examined.
2. Methods
2.1. Preparation of HSE. Hibiscus sabdariﬀa L. was pur-
chased from the Taitung Hsien Farmers’ Association and
identiﬁed by Associate Professor Yi-Ching Li, Chung Shan
Medical University. A voucher specimen has been kept for
future reference at the Department of Pharmacology, Chung
Shan Medical University. HSE was prepared as previously
described [16]. Brieﬂy, 150g of dried ﬂowers was macerated
with hot water (95◦C, 6000mL) for 2 hours and the
aqueous extract was evaporated under vacuum at −85◦C.
The extracted solution was ﬁltered and then lyophilized
t oo b t a i n7 5 go fH S Ea n ds t o r e da t4 ◦C before use. The
concentration of total phenols was analyzed according to
the Folin-Ciocalteau method [19]. Brieﬂy, HSE (0.1mg)
was dissolved in 1mL of distilled water, and then mixed
with Folin–Ciocalteu reagent (2 N, 0.5mL) thoroughly. After
an interval of 3min, 3mL of 2% Na2CO3 solution was
added, and the mixture was allowed to stand for 15min
with intermittent mixing. The absorbance of the mixture at
750nm was measured on a Hitachi spectrophotometer (U-
3210) with gallic acid as the standard. Total anthocyanins
content in HSE was determined using the Fuleki and Francis
method [20]. Ten milliliters of HSE (1mgmL−1) was diluted
to 50mL with the pH 1.0 and 4.5 buﬀers, respectively.
The O.D. of the samples was measured at 535nm, using
distilled water as blank. The O.D. diﬀerence was obtained by
subtracting the total O.D. at pH 4.5 from the total O.D. at
pH 1.0. Both values were calculated from the O.D. readings
using the appropriate dilution and calculation factors. Total
ﬂavonoids content was determined by the Jia method [21]
using rutin as a standard. Half of a milliliter of the HSE
(1mgmL−1) was diluted with 1.25mL of distilled water.
Then, 75μLo fa5 %N a N O 2 solution was added to the
mixture. After 6min, 150μL of a 10% AlCl3·6H2Os o l u t i o n
was added, and the mixture was allowed to stand for another
5min. A 0.5mL amount of 1MNaOH was added, and
the total was made up to 2.5mL with distilled water. The
solution was well mixed, and the absorbance was measured
immediately against the prepared blank at 510nm. The ﬁnal
extract (HSE) was composed of 1.43% ﬂavonoids, 2.5%
anthocyanins, and 1.7% polyphenolic acid, as measured by
quantitative analysis.
2.2. Animal Treatment and Experimental Design. All animal
experimental protocol used in this study was approved
by the Institutional Animal Care and Use Committee
of the Chung Shan Medical University (IACUC, CSMC),
Taichung, Taiwan. Male Sprague-Dawley (SD) rats (180 ±
10g) used in the studies was purchased from the National
Laboratory Animal Breeding and Research Center (Taipei,
Taiwan). The animals were housed in laboratory conditions
(18–23◦C, humidity 55–60%, 12 hours light/dark cycle) for
at least 1 week before each study. Rats were made diabetic
by intraperitoneal injection of STZ (dissolved in 0.05M of
citrate buﬀer, pH 4.5) one time, 65mgkg−1 body weight.
Seventy-two hours after STZ administration, fasting blood
was collected from the tail vein of all the animals in the
experiment to determine the glucose concentration using
a reﬂectance meter (ACCU-CHEK 503363). Animals which
were administered with STZ and those in which glucose
concentration was <250mgdL−1 were excluded from the
study. Blood glucose and body weight were checked every
week.Theratswereprovidedwithstandardizedfood(Purina
Laboratory Chow, obtained from Purina Mills, Inc., USA)
and water ad libitum. The rats were divided into ﬁve groups
with ﬁve rats per group. The control group was fed with
a standardized diet without any treatment. Buﬀer control
group, intraperitoneally injected with 0.05M citrate buﬀer
(pH 4.5) was fed with a standardized diet. STZ group was
diabetic rats fed with standardized diet. HSE 100mgkg−1
group was diabetic rats tube-fed with HSE 100mgkg−1
per day. HSE 400mgkg−1 group was diabetic rats tube-fed
with HSE 400mgkg−1 per day. After treating with HSE for
8 weeks, the rats were sacriﬁced. Blood was collected for
analysis of blood glucose, plasma lipid proﬁles and renal
function. The kidneys were quickly removed on ice and
homogenized in lysis buﬀer. Aliquotes were stored in −70◦C.
Total protein concentration in each sample was determined
by Coomassie blue assay (KENLOR Industries Inc., CA,
USA).
2.3. Determination of Glucose, Creatinine (Cr), Albumin and
Blood Urea Nitrogen (BUN). Plasma glucose, creatinine,
albumin and Blood Urea Nitrogen (BUN) were measuredEvidence-Based Complementary and Alternative Medicine 3
byenzymaticcolorimetricmethodsusingautomaticanalyzer
(Olympus AU2700, Olympus Co., Tokyo, Japan).
2.4. Plasma Lipid Measurements. Concentration of total
cholesterol, triglyceride (TG), low density lipoprotein-
cholesterol(LDL-C)andhighdensitylipoprotein-cholesterol
(HDL-C)weremeasuredbyenzymaticcolorimetricmethods
using commercial kits (Boeheringer Mannheim, Germany).
2.5. Pathological Histology of Kidney. After removal from the
rats, renal tissues were immediately ﬁxed in 10% buﬀered
formaldehyde and processed for histological examination by
conventional methods with hematoxylin and eosin (H&E)
stain. The kidney lesions were observed according to mor-
p h o l o g yc h a n g e s ,s u c ha sh y d r o p i cc h a n g e ss e e na sp a l ea n d
swollen. The severity of kidney damage was evaluated by
examining the sections under ﬁve randomly selected high
power ﬁelds (×200). Image Pro Plus 4.0 was used to quantify
the percentage areas of lesions in kidney specimens.
2.6. Thiobarituric Acid-Reacting Substances (TBARS). Rat
lipid peroxidation was determined by measuring the Thio-
barituric Acid-Reacting Substances (TBARS). Kidney tissue
of 0.5g of was homogenized with 5mL of RIPA buﬀer
(1% NP-40, 50mM Tris-base, 0.1% SDS, 0.5% deoxycholic
acid, and 150mM NaCl, pH 7.5 with 10μgmL −1 leupeptin,
10μgmL −1 PMSF and 17μgmL −1 sodium orthovanadate)
and centrifuged (1000g) for 30min to obtain supernatant
homogenate. Protein content of the supernatant was deter-
mined with Bio-Rad protein assay reagent using bovine
serum albumin as a standard. The 0.3mL of homogenate
was then added with 0.3mL of TBA (1% thiobarbituric acid
in 0.3% of NaOH) and the mixture was allowed to react
for 40min at 95◦C in the dark. After the reaction, samples
were analyzed in a Hitachi F2000 spectrophotoﬂuorimeter
with excitation at 532nm and emission at 600nm. The
concentrations of TBARS were expressed as equivalents of
malondialdehyde (MDA) represented as μMmg −1 protein.
2.7. Determination of GSH Content. The kidney GSH con-
tent was determined according to the method of Hissin
and Hilf [22]. The stock solution of the ﬂuorescent probe
o-phthalaldehyde (OPT) was freshly prepared in methanol
(1mgmL−1). A total of 10μL of the homogenate was mixed
with OPT and incubated in the dark for 15min. We then
monitored the ﬂuorescence intensity with excitation wave-
length at 350nm and emission wavelength at 420nm. We
established a GSH calibration curve to normalize the GSH
concentration. The GSH result was expressed as ngmg−1
protein.
2.8. Catalase Assay. Catalase activity in rat kidney homo-
genate was assayed according to a previous method [23].
Brieﬂy, 20μL of homogenate was added to 980μLo fH 2O2
solution (containing 30μL of ddH20, 50μL of Tris–HCl-
EDTA, pH 8.0 and 900μLo f1 0 m M H 2O2). After 10 s at
room temperature, the optical density of H2O2 was recorded
at 240nm for 1min using a spectrophotometer. A unit of
catalase activity was deﬁned in H2O2 consumed units/mg
protein.
2.9. Preparation of Cell Extracts and Immunoblot Analysis.
Total proteins of tissue samples were extracted by incubating
the cells with 200μLo fc o l dl y s i sb u ﬀer (50mM Tris–
HCl, pH 7.4; 1mM NaF; 150mMNaCl; 1mM EGTA;
2mM phenylmethylsulfonyl ﬂuoride; 0.1% Triton X-100;
and 10μgmL −1 leupeptin) on ice for 30min, followed by
centrifugation at 1000g for 10min at 4◦C. Protein con-
centration of the supernatant was measured by Coomassie
blue assay. Samples (50μg of protein) were mixed with 5×
sample buﬀer (0.4M Tris–HCl, pH 6.8, 0.5M dithiothreitol,
10% SDS, 50% glycerol and 0.005% bromophenol blue).
T h em i x t u r e sw e r eb o i l e da t9 5 ◦Cf o r5m i na n ds u b j e c t e d
to separation on 8% SDS polyacrylamide gels at a constant
voltage of 160V. Following electrophoresis, proteins on
the gel were electro-transferred onto an immobile mem-
brane (nitrocellulose; Millipore Corp., Bedford, MA) with
transfer buﬀer (25mM Tris–HCl, 192mM glycine, and
20% methanol). The membrane was blocked with blocking
solution (20mM Tris-base, pH 7.4, 125mM NaCl, 0.1%
Tween 20, and 1% bovine serum albumin). The membranes
were then immunoblotted with the primary antibodies (Akt,
1:1000; phosphor-Akt, 1:1000; Bad, 1:1000; phosphor-
Bad, 1:1000 and 14-3-3γ, 1:1000, all purchased from
Santa Cruz Biotechnology, CA). The reacted bands were
revealed by enhanced chemiluminescence using an ECL
commercial kit, and the relative photographic negatives by a
gel documentation and analysis system (Alpha Imager 2000,
Alpha Innotech Corp., San Leandro, CA).
2.10. Electrophoretic Mobility Shift Assay (EMSA). The nu-
clear protein extracts from kidney tissues were prepared
as described previously [24]. Protein concentrations were
measured using Coomassie blue assay with bovine serum
albuminasstandard.Double-strandedoligonucleotidescon-
taining the consensus sequence for NF-κB/DNA binding
site (Promega, Madison, WI) were end-labeled with chemi-
luminescence. Nuclear extracts (2μg) were incubated with
Biotin-labeled probe at room temperature for 20min in a
binding buﬀer containing poly (dI-dC). The speciﬁcity of
the binding reaction was determined by preincubation either
with100-foldmolarexcessofunlabeledNF-κBpr obeorwith
monoclonal anti-NF-κB antibodies (anti-p65, Santa Cruz
Biotechnology). DNA-protein complexes were separated in
6% nondenaturing polyacrylamide gel at 90V for 2-3h.
After transferring and hybridizing with HRP-conjugated
streptavidin, the reacted bands were revealed by enhanced
chemiluminescence using an ECL commercial kit, and the
relative photographic negatives by a gel documentation and
analysis system (Alpha Imager 2000, Alpha Innotech Corp.,
San Leandro, CA).
2.11. Statistical Analysis. Statistical analysis was done using
Microsoft Excel 2007 and Sigma plot version 9.0. Results are
presented as mean ± SD. Statistical diﬀerences were analyzed
by Student’s t-test. P < .05 was considered statistically
signiﬁcant.4 Evidence-Based Complementary and Alternative Medicine
3. Results
3.1. Plasma Biochemical Parameters Proﬁling in Various Rats
Groups. The body weight and biochemical markers includ-
ing lipid proﬁles were presented in Table 1.T h e r ew a sa
remarkable decrease in the body weight of STZ-induced
diabetic rats (P < .01). The STZ-induced diabetic rats had
signiﬁcantly increased blood glucose concentration com-
pared with rats in control group (P < .01). HSE treatment
was not able to attenuate the elevated blood glucose value
in STZ diabetic rats. There were no diﬀerences in plasma
sodium (Na), potassium (K) and chloride (Cl) values among
control rats, diabetic rats and HSE-treated rats. The diabetic
rats had higher values of plasma BUN than control rats. But
there was no diﬀerence in plasma Cr level between control
rats and diabetic rats. HSE treatment had no signiﬁcant
inﬂuence on BUN and Cr concentrations. Albumin value
declined signiﬁcantly in STZ diabetic rats. HSE at dose
100mgkg−1 could not improve the albumin value but a
higher dose of HSE (400mgkg−1) could restore albumin
level remarkably.
3.2. Improvements in Hyperlipidemia by HSE. Among lipid
proﬁles, plasma total cholesterol concentrations (P < .01)
and TG (P < .01) increased prominently in STZ diabetic
rats compared to control rats. After HSE treatment, the
TG level reduced signiﬁcantly at HSE dose dependently
(100mgkg−1: P < .05; 400mgkg−1: P < .01). However, HSE
treatment did not aﬀect total cholesterol value. Obviously,
LDL-C value rose remarkably in STZ diabetic rats (P < .01).
Although HSE at dose of 100mgkg−1 could not reduce LDL-
C level, higher HSE dose at 400mgkg−1 could decrease LDL-
Cconcentrationsigniﬁcantly(P <.05).Inaddition,wefound
HDL-ClevelswerecomparablebetweencontrolratsandSTZ
diabetic rats. Only higher dose of HSE (400mgkg−1)c o u l d
improve HDL-C value considerably (P < .05).
3.3. Attenuation on Kidney Lesions in STZ-Induced Diabetic
Rats by HSE. The pathological change of STZ induced
diabetic renal tissues was evaluated under light microscope
(Figure 1). On histological examination, there was remark-
able hydropic change over proximal tubules in renal tissues
of STZ induced diabetic rats. Treatment of diabetic rats with
HSE 100 and 400mgkg−1, the hydropic change in diabetic
renal tissues were decreased prominently (Figure 2).
3.4. HSE Protect Kidney from Oxidative Stress. T h el e v e l so f
MDA, CAT and GSH were depicted in Table 2.M D Ae x -
tracted from renal tissues of STZ diabetic rats was substan-
tially increased compared to control rats. Treatment of STZ
rats with HSE at doses, 100 and 400mgkg−1 signiﬁcantly
diminished MDA formation. In diabetic rats, there was a
signiﬁcant decrease in renal CAT activity (P < .01) and GSH
level (P < .01). HSE at only 100mgkg−1 only signiﬁcantly
improved CAT levels (P < .01) in kidney tissues of diabetic
rats. But HSE at 400mgkg−1 signiﬁcantly increased both
CAT (P < .01) and GSH (P < .01) levels.
3.5. Increase in Expressions of Akt/Bad/14-3-3γ and NF-κBb y
HSE. We measured the expression of Akt signaling cascade.
In Figure 3, there was a remarkable decrease by 30% in p-Akt
expression in renal tissues of STZ diabetic rats compared to
control rats. Both treatments with HSE 100 or 400mgkg−1
increasedp-Aktexpressionby22%and28%,respectively.We
also found that p-Bad protein expression was signiﬁcantly
declined by 22% in kidney tissues of STZ rats compared to
control rats. Similarly, HSE at doses 100 and 400mgkg−1
was found to increase p-Bad protein expression by 25% and
28%, respectively compared to diabetic rats. The expression
of 14-3-3γ protein in renal tissues of STZ rats was reduced by
33% compared to control rats. We found that treatment with
HSE100mgkg−1 increasedtheexpressionof14-3-3γ protein
by 26% and HSE 400mgkg−1 by 35% compared to diabetic
rats. As shown in Figure 4, although the level of NF-κB
activity was decreased in diabetic rats, HSE at doses 100 and
400mgkg−1 increased NF-κB activity compared to diabetic
rats, but it was unrelated to AP-1 regulated transcription
(data not shown).
4. Discussion
Atherogenic dyslipidemia comprises the triad of high LDL-
C, high TG and low HDL-C values and is a part of metabolic
syndrome. It is well established that hyperlipidemia is a
strong risk factor of cardiovascular disease in type 1 and
type 2 diabetic patients [25]. Moreover, hyperlipidemia
predicts progressive loss of renal function in chronic kidney
disease in both type 1 [26]a n dt y p e2[ 27] diabetes. In
our study, plasma cholesterol, TG and LDL-C levels are
increased signiﬁcantly in STZ diabetic rats, while plasma
HDL-C value is found decreased prominently in diabetic
rats. This ﬁnding is consistent with previous studies of
diabetic rats induced by STZ [28]o ra l l o x a n[ 29]. In this
study, we found that HSE have the capacity of decreasing
TG and LDL-C signiﬁcantly in STZ diabetic rats. The results
are in accordance with previous studies in diabetic [28, 29]
or hypercholesterolemic [15, 16] animals. Furthermore, HSE
(400mgkg−1) could increase HDL-C level signiﬁcantly in
our experimental animals. It is implied that HSE might
possess a promising eﬀect on deceleration of metabolic
syndrome in diabetes.
Previous study shows an increasing oxidative stress and
reducing anti-oxidative ability in diabetes [30]. Oxidative
stress results in glomerular sclerosis, renal tubular injury,
proteinuria and leads to gradual loss of renal function
[31]. Excessive production of ROS by oxidative stress in
hyperglycemic status might result in decline of GSH value
[32]. Hibiscus sabdariﬀa L. contained a variety of bioactive
compounds with antioxidant properties, such as protocat-
echuic acid, catechin and (−)-epigallocatechin gallate [33].
They could scavenge harmful free radicals and regenerate
other antioxidants to prevent cellular oxidative damages.
Protocatechuic acid could attenuate diabetic complications
via elevation of GSH and CAT activities in kidney and sig-
niﬁcant reduction in plasma C-reactive protein, interleukin-
6 and other inﬂammatory cytokines [34]. Previous study
also demonstrates that catechin has protective eﬀects on
STZ diabetic rats. Catechin treatment signiﬁcantly reduces
albumin excretion rate in diabetic rats and normalizes theEvidence-Based Complementary and Alternative Medicine 5
Table 1: Physiological and biochemical parameters of rats in various groups (mean ± standard deviation).
Normal Control STZ STZ + HSE STZ + HSE
(100mgkg−1) (400mgkg−1)
Body weight (g) 393.33 ± 11.55 406.67 ± 20.82 240.00 ± 14.14 (b) 205.00 ± 36.97 (b) 206.00 ± 28.81 (b)
Glucose (mg dL−1) 145.33 ± 17.21 141.33 ± 11.06 630.00 ± 77.19 (b) 598.25 ± 67.29 (b) 607.65 ± 16.78 (b)
BUN (mgdL−1) 18.20 ± 1.64 15.23 ± 1.33 34.08 ± 5.12 (b) 31.88 ± 6.67 (b) 35.25 ± 3.15 (b)
Creatinine (mgdL−1)0 . 4 7 ± 0.06 0.50 ± 0.10 0.52 ± 0.04 0.46 ± 0.05 0.50 ± 0.08
Albumin (g dL−1)3 . 3 0 ± 0.10 3.33 ± 0.31 2.84 ± 0.30 (b) 2.90 ± 0.14 3.20 ± 0.08 (d)
Cholesterol (mgdL−1) 59.00 ± 5.00 50.00 ± 3.61 106.67 ± 9.87 (b) 101.75 ± 21.93 (a) 108.25 ± 14.93 (b)
Triglyceride (mgdL−1) 139.700 ± 65.70 88.00 ± 35.60 859.00 ± 196.00 (b) 363.00 ± 127.80 (b),(c) 265.50 ± 46.90 (b),(d)
HDL-C (mgdL−1) 24.00 ± 1.73 22.00 ± 2.65 21.00 ± 5.24 35.80 ± 13.59 54.25 ± 15.13 (b),(c)
LDL-C (mgdL−1)8 . 6 7 ± 1.53 9.00 ± 0.00 17.60 ± 3.05 (b) 16.80 ± 6.94 12.50 ± 3.70 (c)
Sodium (mmol l−1) 144.30 ± 0.60 148.00 ± 4.00 143.20 ± 1.50 144.80 ± 1.90 144.50 ± 1.30
Potassium (mmol l−1)7 . 3 7 ± 0.23 8.27 ± 0.75 6.54 ± 0.58 6.30 ± 0.28 6.10 ± 0.61
Chloride (mmol l−1) 101.33 ± 0.58 103.67 ± 2.52 97.00 ± 3.39 98.80 ± 3.49 101.50 ± 1.00
n = 5. (a)P < .05; (b)P < .01 signiﬁcantly diﬀerent from control group; (c)P < .05, (d)P < .01 signiﬁcantly diﬀerent from STZ group.
(a) (b) (c)
(d) (e)
Figure 1: Eﬀects of HSE on diabetic nephropathy in rats. Histological examination (200×) in rat kidney of (a) normal group, (b) citrate
buﬀer group, (c) STZ-treating group, (d) STZ + 100mgkg−1 day−1 of HSE, (E) STZ + 400mgkg−1 day−1 of HSE. Arrows represent the
hydropic changes seen as pale and swollen in proximal convoluted tubules.
interstitial ﬁbrosis completely in diabetic kidney [35]. Pre-
vious investigation shows that (−)-epigallocatechin gallate
could alleviate renal damage in STZ diabetic rats by suppres-
sion of hyperglycemia, proteinuria, and lipid peroxidation
[36]. Anthocyanins (including cyanidin and delphinidin)
have strong antioxidant activity in a liposomal system [37]
and could ameliorate hyperglycemia and insulin sensitivity
in diabetic mice [38]. In this study, our data shows HSE
could reduce MDA level in kidney tissues signiﬁcantly, and
improveCATandGSHactivitiessigniﬁcantlyinSTZdiabetic
rats. The results show that HSE possesses potent antioxidant
eﬀects on diabetes.
A detailed pathogenesis of diabetic nephropathy is still
not clear. It is considered as primarily a glomerular disease,
including thickening of glomerular basement membrane,
mesangial expansion and podocyte loss. However, recent
evidencedemonstratesthatchronichypoxiaofthetubuloint-
erstitium has a pathogenic role in diabetic nephropathy [39].
In our study, we did not ﬁnd typical diabetic pathological
change of Kimmelsteil-Wilson nodules in glomerulus. The
ﬁnding might result from too short duration to induce
obvious glomerular changes. Indeed, only minor or even no
glomerular change is reported in early diabetic renal tubular
injury [40]. In the present study, renal tubules have hydropic
change, characterized by pale and swollen change of the
proximalconvolutedtubulesinSTZdiabeticrats,asreported
previously [41]. The feature maybe a manifestation of
osmotic diuresis resulting from high glucose concentration.
After HSE administration, signiﬁcant decrease of hydropic
change of renal tubules is noted. Because HSE has no6 Evidence-Based Complementary and Alternative Medicine
Table 2: Antioxidant enzyme proﬁles and marker of oxidative stress in renal tissues of rats from the diﬀerent study groups (mean ± SD).
Normal Buﬀer STZ group S T Z+H S E S T Z+H S E
(100gkg−1) (400gkg−1)
MDA (Mmg−1 protein) 2.83 ± 0.78 3.32 ± 0.78 4.04 ± 0.51 (a) 2.74 ± 0.72 (d) 2.31 ± 0.43 (d)
Catalase (Units mg−1 protein) 11.21 ± 4.78 11.25 ± 5.22 6.11 ± 3.03 (b) 24.97 ± 6.93 (d) 34.00 ± 8.81 (d)
GSH (ngmg−1 protein) 9.28 ± 0.40 9.63 ± 0.33 6.80 ± 0.29 (b) 6.28 ± 0.25 9.25 ± 0.54 (d)
n = 5. (a)P < .05; (b)P < .01 signiﬁcant diﬀerently from control group; (c)P < .05; (d)P < .01 signiﬁcant diﬀerently from STZ group.
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Figure 2: Quantitative determination of the percentage of hydropic
change. #P < .05, signiﬁcant diﬀerences compared with the control;
∗P < .05, ∗∗P < .005, compared with the STZ group.
signiﬁcant eﬀect on blood sugar level in this study, we have
good reason for thinking that the antioxidant eﬀect might
contribute to attenuation of structural changes in renal
tubules.
ThecapacityofinsulintoactivateAktsignalingcascadeis
impairedinhyperglycemia.Intype2DM,PI3K-Aktpathway
is considered a site of insulin resistance [42, 43]. However,
in type 1 DM, the Akt activity in a variety of tissues is not
yet determined. Sheu et al. demonstrates that hyperglycemia
leads to increased phosphorylation and activity of Akt in
murine and rat glomerular mesangial cells [14]. In addition,
Lee et al. reports that high glucose has sustained stimulation
to PI3K activity with following augmented eﬀect of Akt
activity in glomerular epithelial cells in STZ diabetic rats
[13]. Conversely, some other studies disclose that lack of
insulin or hyperglycemia in type 1 DM results in lower
Akt activities. Kondo et al. ﬁnds decreased Akt protein and
phosphorylation of Akt in retinal tissue of STZ diabetic
rats [44]. And Laviola et al. also shows decreased phos-
phorylation of Akt and Akt activity in myocardiocytes of
STZ diabetic rats [45]. Moreover, Zdychov´ a et al. reports
reduction in phosphorylation and activity of Akt in renal
tissues of diabetic animals. The restoration of Akt activity
and phosphorylation of Akt is noted after administration
of insulin [12]. The conﬂicting results of Akt expression
Akt
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14-3-3γ
1.28 1.26
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Figure 3: Eﬀect of HSE in the protein expressions of phospho-
rylated Akt, phosphorylated Bad and 14-3-3γ in rat kidneys. The
expressions of p-Akt, p-Bad and 14-3-3γ were done as described in
the text. The data are repeated for three independent examinations.
from previous studies might result from diﬀerent tissues
or individual exposure duration to high glucose in diabetic
animals.
In fact, oxidative stress is one of the important factors
involved in impairment of Akt activation in hyperglycemia
status. Overproduction of H2O2 in adipocytes would result
in signiﬁcant reduction of Akt phosphorylation in the
previous study [46]. Moreover, tumor necrosis factor-α,
an inﬂammatory cytokine, has been identiﬁed to stimu-
late natural antagonist of ceramide with suppression of
Akt phosphorylation [47]. It has been demonstrated that
high glucose-induced oxidative stress by peroxynitrite could
inhibit activity of Akt-1 kinase and increase the activity
of p38MAP kinase [48]. In our results, expression of p-
Akt, p-Bad and 14-3-3γ protein is found decreased in STZ
diabetic rats compared to normal rats. All of them are
found to recover signiﬁcantly after HSE treatment at dose
of 100 or 400mgkg−1. It seems reasonable to suppose that
HSE could restore Akt level and following signaling cascade
through improvement of oxidative stress in diabetic rats.Evidence-Based Complementary and Alternative Medicine 7
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Figure 4: Eﬀect of HSE on the NF-kB activity. The activity of NF-
κB was performed with EMSA as described in the text. The data are
repeated for three independent examinations.
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Figure 5: Proposed mechanisms of HSE ameliorating diabetic
nephropathy in an experimental animal model. Dashed oval means
inhibition.
However, not all previous studies agree that HSE could
increase Akt expression. HSE is found to block the PI3-
K/Akt pathway with following declined Akt phosphorylation
during adipocyte diﬀerentiation in 3T3-L1 cells [49]. We
have no deﬁnite explanations of these disparate results. This
issue needs further examination to clarify the relationship
between HSE and Akt.
In previous studies, markedly low Akt phosphorylation
expression is seen associated with enhancement of apoptosis
of high glucose-stressed mesangial cells in STZ diabetic
rats [50]. On the other hand, high glucose stimulates
increasing p-Akt level and mesangial cells proliferation in
diabetic rats [14]. Promotion of cell survival by Akt involves
various mechanisms. Akt could directly phosphorylate Bad
proteinwithcombinationof14-3-3γ proteintoactivateanti-
apoptotic eﬀect [51]. In addition, Akt appears to positively
regulate pro-survival transcriptional factors, such as NF-
κB, for controlling cell survival [43]. NF-κB could regulate
gene expression in inhibition of apoptosis and enhances cell
proliferation and angiogenesis [9]. In our study, it might be
assumed that increased activity of Akt and NF-κBh a v ea n
impactonattenuationofdiabeticnephropathythroughanti-
apoptotic eﬀect. Although NF-κBi sf o u n dt ob ea c t i v a t e d
by oxidative stress in diabetic nephropathy [31], and might
involve in the pathophysiology of diabetic microangiopathy
[52], we speculate that the NF-κB-dependent pathway has
diﬀerent regulations among a variety of tissues during
various stages of diabetic nephropathy.
Taken together, our data show that HSE possesses strong
antioxidant properties as well as lipid-lowering eﬀect. HSE
not only can signiﬁcantly decrease TG and LDL-C levels but
also increase HDL-C value. Moreover, HSE is demonstrated
to have potential attenuation eﬀect on diabetic nephropathy
through its anti-oxidative and anti-apoptotic mechanisms
(Figure 5). Limited by the relatively small sample size of
animals, we need further studies to elucidate the relationship
between HSE and Akt pathway in diabetes and to clarify the
detailed mechanisms of HSE on improvement in diabetic
nephropathy. From our results, HSE shows therapeutic
promise in amelioration of hyperlipidemia and prevention
of metabolic syndrome in diabetic patients.
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